Stocktwits on MSN
HIMS stock slips overnight after FDA staff questions safety of popular peptides — but one analyst says 'this isn't the end'
FDA staff said there was insufficient evidence to support compounding BPC-157, Emideltide, Epitalon, KPV, MOTS-c, Semax, and TB-500. ・The agency also said safety concerns could not be ruled out, ...
Stocktwits on MSN
HIMS stock eyes big monthly win: Novo Nordisk calls Hims & Hers one of its most 'voluminous' telehealth partners
Hims partnered with Novo Nordisk in March to offer branded weight-loss drugs. ・Employer GLP-1 coverage cuts could push more patients toward cash-pay telehealth platforms such as Hims. ・Hims’ GLP-1 ...
Hims & Hers' stock rebounded from below $14 after a regulatory shock and is now trading above $37 on a diversified growth narrative. Click to learn more.
Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results